A recent study has found that nearly 54% of patients with type 2 diabetes (T2D) suffer from fatty pancreas disease (FPD).
Chronic pancreatitis is now recognized as a complex fibroinflammatory disorder involving genetic, environmental, and metabolic factors.
The FDA has approved the first medication for cholestatic pruritus in adult patients with primary biliary cholangitis.The approval of linerixibat (Lynavoy, GSK) — an ileal bile acid transporter ...
Obesity increases the body's need for insulin, forcing cells in the pancreas known as beta cells to ramp up insulin ...
A recent Nature article on novel GLP-1 therapies underscores a truth few key opinion leaders in medicine like to focus on: Even the most clinically impactful pharmaceutical accomplishments carry ...
"Prevention and early detection remain some of the most powerful tools we have to reduce cancer risk in the future." ...